Systemic treatment of advanced hepatocellular carcinoma in Germany – First results from the prospective national intersectoral cohort study JADE. 11. November 2022 Schröder, J., Berg, T., Freiberg-Richter, J., Schlenska-Lange, A., von der Heyde, E., Schuler, M.K., Uhlig, J., Weinberg, F., Potthoff, K., Jänicke, M., Hofmann, W.P., Pereira, P., Thimme, R., Galle, P.R., 2022. Oncol Res Treat 2022;45(suppl 2):11–346 Download First Real-World outcome data of SCLC in Germany – Data from the Clinical Research platform Into molecular testing, treatment and outcome of (non-)Small cell lung carcinoma Patients (CRISP; AIO-TRK-0315) M. Sebastian, M. Reck, R. Fischer, D. Christoph, C. Bernhardt, E. von der Heyde, A. Nusch, P. Ludwig, A. Hipper, J. Hanselmann, T. Medinger, A. Weiterlesen Current second-line treatment of patients with multiple myeloma – First outcome data of routine care treatment of patients with multiple myeloma in Germany – results from the MYRIAM registry. Dechow, T., Einsele, H., Schweigert, M., Nusch, A., Jacobasch, L., Spohn, C., Kiewe, P., Gaska, T., Mahlmann, S., Strumberg, D., Jänicke, M., Potthoff, K., Medinger,… Weiterlesen